$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/19
  • A61K-031/135
출원번호 US-0598502 (1984-04-09)
발명자 / 주소
  • Sunshine, Abraham
  • Laska, Eugene M.
  • Siegel, Carole E.
출원인 / 주소
  • Analgesic Associates
대리인 / 주소
    Burns, Doane, Swecker & Mathis
인용정보 피인용 횟수 : 48  인용 특허 : 0

초록

Pharmaceutical compositions and methods of using same comprising a non-steroidal anti-inflammatory drug in combination with at least one other active component selected from an antihistamine, decongestant, cough suppressant (antitussive) or expectorant are provided for the relief of cough, cold and

대표청구항

1. A pharmaceutical composition of matter for use in the treatment of cough, cold, cold-like and/or flu symptoms in a mammalian organism, said composition comprising a sympathomimetically, analgesically and anti-inflammatorily effective amount of (i) at least one of the propionic acid NSAIDs, ibupro

이 특허를 인용한 특허 (48)

  1. Kou Jim H., 8-chloro-6,11-dihydro-11- ] (4-piperidylidine)-5H-benzo[5,6]cyclohepta[1,2-bpyridine oral compositions.
  2. Ohannesian Lena A. ; Nadig David ; Higgins ; III John D. ; Rey Max,SEX ; Martellucci Stephen A., Alkali metal and alkaline-earth metal salts of acetaminophen.
  3. Kositprapa, Unchalee; Sriwongjanya, Mongkol, Antihistamine and decongestant system.
  4. Gordziel, Steven A., Antihistaminic/antitussive compositions.
  5. Leflein, Ronald J.; D'Addio, Alexander D., Antitussive/antihistaminic compositions.
  6. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Composition comprising drug, HPC, HPMC and PEO.
  7. Berlin, Roger G., Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines.
  8. Platt Chris E., Controlled release oral preparation with naproxen sodium and pseudoephedrine.
  9. Gordziel Steven A., Decongestant/antihistaminic compositions.
  10. Cho, Wing Kee Philip, Extended release oral dosage composition.
  11. Cho, Wing-Kee Philip, Extended release oral dosage composition.
  12. Cho, Wing-Kee Philip, Extended release oral dosage composition.
  13. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Lamina comprising carboxyvinyl polymer.
  14. Haas Ronald T. (West Windsor Township ; Mercer County NJ), Liquid ibuprofen compositions and methods of making them.
  15. Clark ; Jr. Joseph D. (Randolph NJ) Myers Ivan T. (Bernardsville NJ) Kornman Kenneth S. (San Antonio TX) Holt Stanley C. (San Antonio TX), Method of and compositions for treating destructive periodontal disease.
  16. Kushla, Gregory P.; Lai, Jin-Wang; Polli, Gerald P., Method of making ibuprofen and narcotic analgesic compositions.
  17. Sriwongjanya,Mongkol; Weng,Timothy; Barman,David; Kositprapa,Unchalee, Once a day antihistamine and decongestant formulation.
  18. Sunshine Abraham (New York NY) Laska Eugene M. (Larchmont NY), Onset-hastened/enhanced analgesia.
  19. Shtohryn Liudoslava V. (Budd Lake NJ) Peters David (Long Valley NJ), Pharmaceutical composition.
  20. Schock Herbert (Cincinnati OH) Long David F. (Loveland OH) Nadler William R. (Cincinnati OH), Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination.
  21. Dittmar, Gregory Paul; Amante, Joseph Michael; Cronk, Tony Ryan; Newby, Daniel Gary, Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures.
  22. Dittmar, Gregory Paul; Amante, Joseph Michael; Cronk, Tony Ryan; Newby, Daniel Gary, Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures.
  23. Kiel,Jeffrey S.; Thomas,H. Greg; Mani,Narasimhan, Phenolic acid salts of gabapentin in liquid and/or semi-solid dosage forms and methods of use.
  24. Kiel, Jeffrey S.; Thomas, H. Greg; Mani, Narasimhan, Phenolic acid salts of gabapentin in solid dosage forms and methods of use.
  25. Kiel,Jeffrey S.; Thomas,H. Greg; Mani,Narasimhan, Phenolic acid salts of gabapentin in solid dosage forms and methods of use.
  26. Kiel, Jeffrey S.; Thomas, H. Greg; Mani, Narasimhan, Process for preparing phenolic acid salts of gabapentin.
  27. Kiel, Jeffrey S.; Thomas, H. Greg; Mani, Narasimhan, Process for preparing tannate liquid and semi-solid dosage forms.
  28. Kiel,Jeffrey S.; Thomas,H. Greg; Mani,Narasimhan, Process for preparing tannate liquid and semi-solid dosage forms.
  29. Kiel,Jeffrey S.; Thomas,H. Greg; Mani,Narasimhan, Process for preparing tannate tablet, capsule or other solid dosage forms.
  30. Ayer Atul D. (Mt. View CA) Hamel Lawrence G. (Sunnyvale CA), Pseudoephedrine brompheniramine therapy.
  31. Hamel L. G. (Sunnyvale CA) Landrau Felix A. (Miliptas CA) Wong Patrick S. L. (Hayward CA) Guittard George V. (Cupertino CA), Pseudoephedrine, brompheniramine therapy.
  32. Gelotte Cathy Klech ; Hills Joanna F. ; Pendley ; II Charles E. ; Shah Manoj N., Rapidly absorbed liquid compositions.
  33. Gelotte,Cathy Klech; Hills,Joanna F.; Pendley, II,Charles E.; Shah,Manoj N., Rapidly absorbed liquid compositions.
  34. Kou, Jim H., Stable extended release oral dosage composition.
  35. Kou, Jim H., Stable extended release oral dosage composition.
  36. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release formulations of guaifenesin and additional drug ingredients.
  37. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin.
  38. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin combination drugs.
  39. Davis, Robert D.; Blume, Ralph W.; Keyser, Donald Jeffrey, Sustained release of guaifenesin combination drugs.
  40. Sunshine Abraham (New York NY) Laska Eugene M. (Larchmont NY), Sustained/enhanced analgesia.
  41. Venkataraman, Balaji, Tannate compositions and methods of treatment.
  42. Pankhania Mahendra G. (Nottingham GB2) Meyer Michael C. (Gwent GB7), Therapeutic agents.
  43. Platt Chris E., Timed release tablet comprising naproxen and pseudoephedrine.
  44. Platt Chris, Timed release tablet comprising naproxen and pseudoepherine.
  45. Affrime,Melton B.; Banfield,Christopher R.; Gupta,Samir K.; Padhi,Desmond, Treating allergic and inflammatory conditions.
  46. Harris Alan G. ; Iezzoni Domenic G., Treating sleep disorders using desloratadine.
  47. Harris Alan G. ; Iezzoni Domenic G., Treating sleep disorders using desloratadine.
  48. Haas Ronald T. (West Windsor Township ; Mercer County NJ), Water soluble ibuprofen compositions and methods of making them.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로